Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M98.7Revenue $M6.1Net Margin (%)--Altman Z-Score5.5
Enterprise Value $M27.5EPS $-1.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio13.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio13.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-48.7Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-52.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.3ROIC % (ttm)-266.1Gross Margin Increase y-yN

Gurus Latest Trades with CCXI

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CCXI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CCXI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-22Sell25,764$4.04-44.8view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-20Sell21,405$4.08-45.34view
Parker Geoffrey M.Director 2016-01-11Buy20,000$4.63-51.84view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-08Sell10,224$5.12-56.45view
KANAYA SUSAN MSVP, Finance, CFO and Sec. 2016-01-06Sell47,607$6.98-68.05view
Parker Geoffrey M.Director 2015-12-11Buy20,000$7.25-69.24view
BIOTECHNOLOGY VALUE FUND L P 2015-11-04Sell360,000$7-68.14view
BIOTECHNOLOGY VALUE FUND L P 2015-11-02Sell50,000$6.97-68.01view
BVF PARTNERS L P/IL10% Owner 2015-06-10Sell955,700$9-75.22view
Parker Geoffrey M.Director 2015-05-27Sell13,513$7.51-70.31view

Quarterly/Annual Reports about CCXI:

News about CCXI:

Articles On GuruFocus.com
Three Attractively Priced Small Cap Biotech Stocks Nov 05 2014 

More From Other Websites
ChemoCentryx Receives FDA Orphan Products Development Grant for Orally Administered Complement 5a... Apr 28 2016
ChemoCentryx Announces Immuno-Oncology Data Presentation at the American Association for Cancer... Apr 18 2016
5 Stocks Poised for Big Breakouts Apr 01 2016
CHEMOCENTRYX, INC. Financials Mar 18 2016
Edited Transcript of CCXI earnings conference call or presentation 14-Mar-16 9:00pm GMT Mar 15 2016
ChemoCentryx reports 4Q loss Mar 14 2016
ChemoCentryx reports 4Q loss Mar 14 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 14 2016
ChemoCentryx Reports Fourth Quarter 2015 Financial Results and Provides Corporate Update Mar 14 2016
Q4 2015 ChemoCentryx Inc Earnings Release - After Market Close Mar 14 2016
CHEMOCENTRYX, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 09 2016
ChemoCentryx to Hold Fourth Quarter 2015 Financial Results Conference Call on Monday, March 14, 2016 Feb 29 2016
ChemoCentryx to Present at the Cowen and Company 36th Annual Healthcare Conference Feb 25 2016
ChemoCentryx (CCXI) Rises: Stock Adds 8.2% in Session Feb 10 2016
ChemoCentryx rare-disease drug as effective as standard of care Jan 06 2016
ChemoCentryx drug meets main goal in mid-stage study Jan 06 2016
Biotechnology Equities Update -- Arena Pharma, Compugen, ChemoCentryx, and Concert Pharma Dec 23 2015
A Change in Tides - Analyst Notes on Hemisphere Media Group, AngioDynamics, ChemoCentryx and... Dec 17 2015
What Do Hedge Funds Think of Blount International, Inc. (BLT)? Dec 02 2015
ChemoCentryx (CCXI) Shares March Higher, Can It Continue? Dec 02 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)